[
  {
    "question": "What is the typical duration of the intensive phase for drug-susceptible pulmonary tuberculosis?",
    "options": {
      "A": "1 month",
      "B": "2 months",
      "C": "3 months",
      "D": "4 months"
    },
    "correctAnswer": "B",
    "topic": "tb_treatment",
    "deepDiveExplanation": "The standard regimen for drug-susceptible TB consists of an intensive phase (initial phase) and a continuation phase. The intensive phase typically lasts 2 months, during which four drugs (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol) are administered daily or thrice weekly.",
    "highYieldPearl": "2 months for 4 drugs (HRZE) in the intensive phase of drug-susceptible TB treatment.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "Options are numerical and close. Misremembering the phase or duration is the main trap. Some might confuse it with the total duration (6 months).",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_9mlnzlgg"
  },
  {
    "question": "The continuation phase for drug-susceptible pulmonary tuberculosis typically lasts how many months?",
    "options": {
      "A": "2",
      "B": "3",
      "C": "4",
      "D": "6"
    },
    "correctAnswer": "C",
    "topic": "tb_treatment",
    "deepDiveExplanation": "Following the 2-month intensive phase, the continuation phase for drug-susceptible TB typically lasts 4 months. During this phase, two drugs (Isoniazid and Rifampicin) are usually administered to complete the standard 6-month treatment.",
    "highYieldPearl": "4 months for 2 drugs (HR) in the continuation phase of drug-susceptible TB treatment.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "Similar to the intensive phase question, numerical options can be confusing. Some might confuse it with the total duration (6 months) or the intensive phase duration (2 months).",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_gni4xv6i"
  },
  {
    "question": "Which combination of drugs constitutes the intensive phase for drug-susceptible pulmonary tuberculosis?",
    "options": {
      "A": "Isoniazid, Rifampicin, Pyrazinamide, Ethambutol",
      "B": "Isoniazid, Rifampicin, Ethambutol",
      "C": "Isoniazid, Rifampicin, Pyrazinamide",
      "D": "Isoniazid, Rifampicin"
    },
    "correctAnswer": "A",
    "topic": "tb_treatment",
    "deepDiveExplanation": "The standard intensive phase regimen for drug-susceptible TB includes four drugs: Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), and Ethambutol (E). This is often abbreviated as HRZE.",
    "highYieldPearl": "HRZE for 2 months is the standard intensive phase regimen for drug-susceptible TB.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Options B, C, and D represent incomplete or incorrect combinations, testing precise recall of the standard four-drug regimen. Option D is the continuation phase drugs, a common distractor.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_8hunvt0v"
  },
  {
    "question": "Which drugs are typically used in the continuation phase for drug-susceptible pulmonary tuberculosis?",
    "options": {
      "A": "Isoniazid, Rifampicin, Pyrazinamide",
      "B": "Isoniazid, Rifampicin, Ethambutol",
      "C": "Isoniazid, Rifampicin",
      "D": "Rifampicin, Pyrazinamide"
    },
    "correctAnswer": "C",
    "topic": "tb_treatment",
    "deepDiveExplanation": "The standard continuation phase regimen for drug-susceptible TB includes two drugs: Isoniazid (H) and Rifampicin (R). This is often abbreviated as HR and typically lasts for 4 months.",
    "highYieldPearl": "HR for 4 months is the standard continuation phase regimen for drug-susceptible TB.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Distractors include combinations from the intensive phase (A, B) or other incorrect pairings (D), testing specific knowledge of the two-drug continuation phase.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_3726nr9s"
  },
  {
    "question": "Isoniazid exerts its bactericidal effect primarily by inhibiting the synthesis of what bacterial component?",
    "options": {
      "A": "Peptidoglycan",
      "B": "Mycolic acid",
      "C": "Folic acid",
      "D": "DNA gyrase"
    },
    "correctAnswer": "B",
    "topic": "tb_treatment",
    "deepDiveExplanation": "Isoniazid (INH) is a pro-drug activated by the mycobacterial catalase-peroxidase enzyme KatG. The activated form inhibits the synthesis of mycolic acid, a crucial component of the mycobacterial cell wall, leading to cell death.",
    "highYieldPearl": "INH inhibits mycolic acid synthesis, a key component of the mycobacterial cell wall.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Other options relate to mechanisms of action for other antibiotics (e.g., Peptidoglycan for beta-lactams, Folic acid for sulfonamides/trimethoprim, DNA gyrase for fluoroquinolones), making them plausible distractors if the specific mechanism for INH isn't known.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_bsobgdl9"
  },
  {
    "question": "Rifampicin's primary mechanism of action against Mycobacterium tuberculosis involves inhibiting which enzyme?",
    "options": {
      "A": "Mycolic acid synthase",
      "B": "RNA polymerase",
      "C": "DNA gyrase",
      "D": "Dihydrofolate reductase"
    },
    "correctAnswer": "B",
    "topic": "tb_treatment",
    "deepDiveExplanation": "Rifampicin binds to the beta-subunit of the DNA-dependent RNA polymerase (rpoB gene product) in Mycobacterium tuberculosis, thereby inhibiting bacterial RNA synthesis and leading to cell death.",
    "highYieldPearl": "Rifampicin inhibits bacterial DNA-dependent RNA polymerase (rpoB gene).",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Similar to the INH MOA question, other options relate to mechanisms of action for other antibiotics or other anti-TB drugs, requiring precise knowledge of Rifampicin's specific target.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_195mo0im"
  },
  {
    "question": "Which first-line anti-TB drug is generally contraindicated during pregnancy due to fetal ototoxicity?",
    "options": {
      "A": "Isoniazid",
      "B": "Rifampicin",
      "C": "Pyrazinamide",
      "D": "Streptomycin"
    },
    "correctAnswer": "D",
    "topic": "tb_treatment",
    "deepDiveExplanation": "Streptomycin, an aminoglycoside, is contraindicated in pregnancy due to its established ototoxic effects on the fetus, leading to congenital deafness. Isoniazid, Rifampicin, and Ethambutol are generally considered safe, and Pyrazinamide is also often used in drug-susceptible TB during pregnancy.",
    "highYieldPearl": "Streptomycin (an aminoglycoside) is contraindicated in pregnancy due to fetal ototoxicity.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Pyrazinamide might be considered a trap by some, as its use in pregnancy was historically debated more than the others, but Streptomycin has a clearer, stronger contraindication.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_kgn4j20c"
  },
  {
    "question": "What is the recommended total duration for drug-susceptible tuberculous meningitis treatment?",
    "options": {
      "A": "6 months",
      "B": "9 months",
      "C": "12 months",
      "D": "18 months"
    },
    "correctAnswer": "C",
    "topic": "tb_treatment",
    "deepDiveExplanation": "For drug-susceptible tuberculous meningitis, the recommended total duration of treatment is typically longer than pulmonary TB, usually 9-12 months. Many guidelines, including WHO, recommend 9-12 months, with 12 months often preferred for optimal outcomes in CNS TB.",
    "highYieldPearl": "TB meningitis treatment duration is 9-12 months, with 12 months often targeted.",
    "examStyle": "NEET-SS",
    "difficulty": "Hard",
    "trapAnalysis": "The 6-month option is a strong distractor, being the standard duration for pulmonary TB. 9 months is also a common recommendation, making 12 months the more extended, often preferred, optimal duration in some contexts.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_tc0k2czv"
  },
  {
    "question": "Which novel drug is a key component of shorter, all-oral regimens for multidrug-resistant tuberculosis (MDR-TB)?",
    "options": {
      "A": "Ethambutol",
      "B": "Streptomycin",
      "C": "Bedaquiline",
      "D": "Cycloserine"
    },
    "correctAnswer": "C",
    "topic": "tb_treatment",
    "deepDiveExplanation": "Bedaquiline is a diarylquinoline, a novel anti-TB drug approved for MDR-TB. It is a cornerstone of newer, shorter, and all-oral regimens for MDR-TB, significantly improving treatment outcomes and reducing reliance on injectables.",
    "highYieldPearl": "Bedaquiline is a novel, key drug for MDR-TB in shorter, all-oral regimens.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Ethambutol and Streptomycin are older, conventional drugs. Cycloserine is a second-line drug but not considered 'novel' in the same context as Bedaquiline.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_2y23p1mp"
  },
  {
    "question": "Which single drug regimen for 6-9 months is a standard option for treating latent tuberculosis infection?",
    "options": {
      "A": "Rifampicin",
      "B": "Isoniazid",
      "C": "Pyrazinamide",
      "D": "Ethambutol"
    },
    "correctAnswer": "B",
    "topic": "tb_treatment",
    "deepDiveExplanation": "Isoniazid monotherapy for 6 or 9 months (6H or 9H) is a classic and widely used regimen for treating latent tuberculosis infection (LTBI). Other regimens exist, such as 4 months of Rifampicin (4R) or 3 months of Isoniazid and Rifapentine (3HP), but 6H/9H remains a fundamental option.",
    "highYieldPearl": "INH for 6 or 9 months (6H/9H) is a standard monotherapy for LTBI treatment.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Rifampicin (4R) is another common monotherapy for LTBI but typically for 4 months, not 6-9 months. Pyrazinamide and Ethambutol are not used as monotherapy for LTBI.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|tb_treatment|Pulmonary Tuberculosis - Treatment Regimens|10_pc23vayv"
  }
]